Review of the Early Diagnoses and Assessment of Rejection in Vascularized Composite Allotransplantation

Review of the Early Diagnoses and Assessment of Rejection in Vascularized Composite Allotransplantation

The emerging field of vascular composite allotransplantation (VCA) has become a clinical reality. Building upon cutting edge understandings of transplant surgery and immunology, complex grafts such as hands and faces can now be transplanted with success. Many of the challenges that have historically...

Full description

Bibliographic Details
Main Authors:	Ravi Starzl, Gerald Brandacher, W. P. Andrew Lee, Jaime Carbonell, Wensheng Zhang, Jonas Schnider, Vijay Gorantla, Stefan Schneeberger, Xin Xiao Zheng
Format:	Article
Language:	English
Published:	Hindawi Limited 2013-01-01
Series:	Clinical and Developmental Immunology
Online Access:	http://dx.doi.org/10.1155/2013/402980

Similar Items

Mechanisms and Mediators of Inflammation: Potential Models for Skin Rejection and Targeted Therapy in Vascularized Composite Allotransplantation
by: Theresa Hautz, et al.
Published: (2012-01-01)

Site-Specific Immunosuppression in Vascularized Composite Allotransplantation: Prospects and Potential
by: Jonas T. Schnider, et al.
Published: (2013-01-01)

Perspectives on the Use of Mesenchymal Stem Cells in Vascularized Composite Allotransplantation
by: Jan A. Plock, et al.
Published: (2013-07-01)

Defining chronic rejection in vascularized composite allotransplantation—The American Society of Reconstructive Transplantation and International Society of Vascularized Composite Allotransplantation chronic rejection working group: 2018 American Society of Reconstructive Transplantation meeting report and white paper Research goals in defining chronic rejection in vascularized composite allotransplantation
by: Christina L Kaufman, et al.
Published: (2020-07-01)

Emerging Implications for Extracellular Matrix-Based Technologies in Vascularized Composite Allotransplantation
by: Ricardo Londono, et al.
Published: (2016-01-01)

Abstract: Prevention of Ischemic-Reperfusion Injury and Chronic Rejection in a Porcine Vascularized Composite Allotransplantation Model
by: Nicholas L. Robbins, DO, et al.
Published: (2017-09-01)

A chronic rejection model and potential biomarkers for vascularized composite allotransplantation.
by: Flemming Puscz, et al.
Published: (2020-01-01)

Mycophenolic Acid for Topical Immunosuppression in Vascularized Composite Allotransplantation: Optimizing Formulation and Preliminary Evaluation of Bioavailability and Pharmacokinetics
by: Firuz G. Feturi, et al.
Published: (2018-05-01)

IGF-1 and Chondroitinase ABC Augment Nerve Regeneration after Vascularized Composite Limb Allotransplantation.
by: Nataliya V Kostereva, et al.
Published: (2016-01-01)

Overcoming skin rejection in composite tissue allotransplantation
by: Horner, Benjamin
Published: (2008)

Current status of vascularized composite tissue allotransplantation
by: Karoline Edtinger, et al.
Published: (2014-04-01)

Evolving ethics, policy and reimbursement issues of vascularized composite allotransplantation: Symposium summary
by: John Rose, et al.
Published: (2019-07-01)

Sensitization and Desensitization in Vascularized Composite Allotransplantation
by: Dimitrios Moris, et al.
Published: (2021-08-01)

Costimulation Blockade in Vascularized Composite Allotransplantation
by: Dimitrios Giannis, et al.
Published: (2020-09-01)

Differentiation between Acute Skin Rejection in Allotransplantation and T-Cell Mediated Skin Inflammation Based on Gene Expression Analysis
by: Dolores Wolfram, et al.
Published: (2015-01-01)

Insights from computational modeling in inflammation and acute rejection in limb transplantation.
by: Dolores Wolfram, et al.
Published: (2014-01-01)

The Effects of Tacrolimus on Tissue-Specific, Protein-Level Inflammatory Networks in Vascularized Composite Allotransplantation
by: Ali Mubin Aral, et al.
Published: (2021-05-01)

A Critical Analysis of Rejection in Vascularized Composite Allotransplantation: Clinical, cellular and molecular aspects, Current Challenges, and Novel Concepts
by: Karim A Sarhane, et al.
Published: (2013-11-01)

A Lifesaving View of Vascularized Composite Allotransplantation
by: Katrina A Bramstedt PhD, MA
Published: (2018-06-01)

The Need for Inducing Tolerance in Vascularized Composite Allotransplantation
by: Kadiyala V. Ravindra, et al.
Published: (2012-01-01)

Kidney Dysfunction After Vascularized Composite Allotransplantation
by: Nicco Krezdorn, MD, et al.
Published: (2018-07-01)

Abstract: Belatacept and Rapamycin with Short-Term Use of Tacrolimus Delay Allograft Rejection in a Novel, Large Animal Vascularized Composite Allotransplantation Model
by: Tarek Elgendy, MD, et al.
Published: (2018-09-01)

Abstract 39: Characterization And Functional Analysis Of Skin Dendritic Cell Subpopulations In Vascularized Composite Allotransplantation
by: WENSHENG ZHANG, MD, PhD, et al.
Published: (2018-04-01)

MMP3 Is a Non-invasive Biomarker of Rejection in Skin-Bearing Vascularized Composite Allotransplantation: A Multicenter Validation Study
by: Branislav Kollar, et al.
Published: (2019-11-01)

Abstract 53: Regulatory T Cells Promote Tolerance during the Early Post-Operative Period in Murine Osteomyocutaneous Vascularized Composite Allotransplantation
by: Madonna R. Anggelia, et al.
Published: (2019-04-01)

Immunomodulatory Role of Mesenchymal Stem Cell Therapy in Vascularized Composite Allotransplantation
by: Richard Heyes, et al.
Published: (2016-01-01)

A Call to Accountability: Reporting Outcomes in Vascularized Composite Allotransplantation
by: James L. Benedict, MDiv, STM, DMin, PhD, et al.
Published: (2019-06-01)

Mesenchymal Stem Cells as Immunomodulators in a Vascularized Composite Allotransplantation
by: Yur-Ren Kuo, et al.
Published: (2012-01-01)

Thermosensitive Polypeptide Hydrogel for Immunosuppressive Drug Delivery in Vascularized Composite Allotransplantation
by: Cheng, Chih-Chi, et al.
Published: (2017)

Preservation solutions for attenuation of ischemia–reperfusion injury in vascularized composite allotransplantation
by: Shaishav Datta, et al.
Published: (2021-07-01)

Bioimaging of alloantigen-stimulated regulatory T cells in rat vascularized composite allotransplantation.
by: Hui-Yun Cheng, et al.
Published: (2018-01-01)

The Role of Imaging in Patient Selection, Preoperative Planning, and Postoperative Monitoring in Human Upper Extremity Allotransplantation
by: Eira S. Roth, et al.
Published: (2014-01-01)

Abstract QS20: HIF-1α Deletion Modulates the Ratio of Treg/Th17 cells in CD4 T Cells and Improves Vascularized Composite Allotransplantation Survival under Costimulatory Blockade
by: Cheng-Hung Lin, et al.
Published: (2019-04-01)

Abdominal wall allotransplantation
by: Martin Molitor, et al.
Published: (2018-09-01)

Modelling and characterisation of in vivo human skin graft rejection for the investigation of regulatory T cell therapy in vascularised composite allotransplantation
by: Issa, Fadi
Published: (2011)

Heart Allograft Tolerance Induced and Maintained by Vascularized Hind-Limb Transplant in Rats
by: Quan Liu, et al.
Published: (2013-01-01)

Tolerance Induction Strategies in Vascularized Composite Allotransplantation: Mixed Chimerism and Novel Developments
by: David A. Leonard, et al.
Published: (2012-01-01)

Abstract 11.25 EXPERIMENTAL MODELS FOR IMMUNOLOGICAL STUDIES IN VASCULARIZED COMPOSITE ALLOTRANSPLANTATION
by: Andreea Grosu-Bularda, et al.
Published: (2018-06-01)

Cardiac Arrest Disrupts Caspase-1 and Patterns of Inflammatory Mediators Differently in Skin and Muscle Following Localized Tissue Injury in Rats: Insights from Data-Driven Modeling
by: Ravi eStarzl, et al.
Published: (2015-11-01)

Tracheal Allotransplantation–Lessons Learned
by: Subramania Iyer, et al.
Published: (2020-08-01)